Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers

Toxicology and Applied Pharmacology

Volumn 199, Issue 3, 2004, Pages 210-219

  Kim, James H ^a   Sherman, Mark E ^b   Curriero, Frank C ^a   Guengerich, F Peter ^c   Strickland, Paul T ^a   Sutter, Thomas R ^a,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MEMPHIS   (United States)

Author keywords

Cytochrome P4501B1; Lung; Polycyclic aromatic hydrocarbons; Smoking

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; IMMUNOGLOBULIN; POLYCLONAL ANTIBODY; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE;

ADULT; AGED; AIRWAY; ARTICLE; CIGARETTE SMOKING; COLUMNAR EPITHELIUM; COMPARATIVE STUDY; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL TYPE 1; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; MALE; MICROSOME; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP1A1; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; MICROSOMES; MIDDLE AGED; PULMONARY ALVEOLI; SMOKING;

EID: 4444362447     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.11.015     Document Type: Article

References (80)

1. Alexandrie A.K., Sundberg M.I., Seidegard J., Tornling G., Rannug A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis. 15:1994;1785-1790
2. Anttila S., Hietanen E., Vainio H., Camus A.M., Gelboin H.V., Park S.S., Heikkila L., Karjalainen A., Bartsch H. Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients. Int. J. Cancer. 47:1991;681-685
3. Anttila S., Vainio H., Hietanen E., Camus A.M., Malaveille C., Brun G., Husgafvel-Pursiainen K., Heikkila L., Karjalainen A., Bartsch H. Immunohistochemical detection of pulmonary cytochrome P450IA and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients. Environ. Health Perspect. 98:1992;179-182
4. Anttila S., Hukkanen J., Hakkola J., Stjernvall T., Beaune P., Edwards R.J., Boobis A.R., Pelkonen O., Raunio H. Expression and localization of CYP3A4 and CYP3A5 in human lung. Am. J. Respir. Cell Mol. Biol. 16:1997;242-249
5. Bauer E., Guo Z., Ueng Y.F., Bell L.C., Zeldin D., Guengerich F.P. Oxidation of benzo[a]pyrene by recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol. 8:1995;136-142
6. Buters J.T., Sakai S., Richter T., Pineau T., Alexander D.L., Savas U., Doehmer J., Ward J.M., Jefcoate C.R., Gonzalez F.J. Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1977-1982
7. Cavalieri E.L., Higginbotham S., RamaKrishna N.V., Devanesan P.D., Todorovic R., Rogan E.G., Salmasi S. Comparative dose-response tumorigenicity studies of dibenzo[alpha,l]pyrene versus 7,12-dimethylbenz[alpha]anthracene, benzo[alpha]pyrene and two dibenzo[alpha,l]pyrene dihydrodiols in mouse skin and rat mammary gland. Carcinogenesis. 12:1991;1939-1944
8. Cohen, J., 1988. Statistical Power Analysis for the Behavioral Sciences, 2nd ed. L. Erlbaum Associates, Hillsdale, N.J., p. xxi, 567.
9. Conney A.H., Chang R.L., Jerina D.M., Wei S.J. Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. Drug Metab. Rev. 26:1994;125-163
10. Conover, W.J., 1980. Practical Nonparametric Statistics, 2nd ed. Wiley, NY, p. xiv, 493.
11. Czerwinski M., McLemore T.L., Gelboin H.V., Gonzalez F.J. Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Res. 54:1994;1085-1091
12. Devereux T.R. Alveolar type II and Clara cells: isolation and xenobiotic metabolism. Environ. Health Perspect. 56:1984;95-101
13. Devereux T.R., Fouts J.R. Xenobiotic metabolism by alveolar type II cells isolated from rabbit lung. Biochem. Pharmacol. 30:1981;1231-1237
14. Devereux T.R., Domin B.A., Philpot R.M. Xenobiotic metabolism by isolated pulmonary cells. Pharmacol. Ther. 41:1989;243-256
15. Gautier J.C., Lecoeur S., Cosme J., Perret A., Urban P., Beaune P., Pompon D. Contribution of human cytochrome P450 to benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol metabolism, as predicted from heterologous expression in yeast. Pharmacogenetics. 6:1996;489-499
16. Gelboin H.V. Benzo[a]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol. Rev. 60:1980;1107-1166
17. Guengerich F.P. Purification and characterization of xenobiotic- metabolizing enzymes from lung tissue. Pharmacol. Ther. 45:1990;299-307
18. Guidice J.M., Marez D., Sabbagh N., Legrand-Andreoletti M., Spire C., Alcaide E., Lafitte J.J., Broly F. Evidence for CYP2D6 expression in human lung. Biochem. Biophys. Res. Commun. 241:1977;79-85
19. Hakkola J., Pasanen M., Pelkonen O., Hukkanen J., Evisalmi S., Antilla S., Rane A., Mäntylä M., Purkunen R., Saarikoski S., Tooming M., Raunio H. Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis. 18:1997;391-397
20. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35:1995;307-340
21. Hasleton, P.S., Spencer, H., 1996. Spencer's Pathology of the Lung, 5th ed. McGraw-Hill, NY,p. xii, 1283.
22. Hayes C.L., Spink D.C., Spink B.C., Cao J.Q., Walker N.J., Sutter T.R. 17 Beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9776-9781
23. Hettmansperger, T.P., 1984. Statistical Inference Based on Ranks. Wiley, NY, p. xviii, 323.
24. Jakobsson S.W., Okita R.T., Mock N.I., Masters B.S., Buja L.M., Prough R.A. Monooxygenase activities of human liver, lung, and kidney microsomes - A study of 42 post mortem cases. Acta Pharmacol. Toxicol. (Copenh.). 50:1982;332-341
25. Karki N.T., Pokela R., Nuutinen L., Pelkonen O. Aryl hydrocarbon hydroxylase in lymphocytes and lung tissue from lung cancer patients and controls. Int. J. Cancer. 39:1987;565-570
26. Kellermann G., Luyten-Kellermann M., Shaw C.R. Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am. J. Hum. Genet. 25:1973;327-331
27. Kellermann G., Shaw C.R., Luyten-Kellerman M. Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med. 289:1973;934-937
28. Kellermann G., Jett J.R., Luyten-Kellermann M., Moses H.L., Fontana R.S. Variation of microsomal mixed function oxidase(s) and human lung cancer. Cancer. 45:1980;1438-1442
29. Kim J.H., Stansbury K.H., Walker N.J., Trush M.A., Strickland P.T., Sutter T.R. Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450. Carcinogenesis. 19:1998;1847-1853
30. Kivisto K.T., Fritz P., Linder A., Friedel G., Beaune P., Kroemer H.K. Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue. Histochem. Cell Biol. 103:1995;25-29
31. Kivisto K.T., Griese E.U., Stuven T., Fritz P., Friedel G., Kroemer H.K., Zanger U.M. Analysis of CYP2D6 expression in human lung: implications for the association between CYP2D6 activity and susceptibility to lung cancer. Pharmacogenetics. 7:1997;295-302
32. Kouri R.E., McKinney C.E., Slomiany D.J., Snodgrass D.R., Wray N.P., McLemore T.L. Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res. 42:1982;5030-5037
33. Landers J.P., Bunce N.J. The Ah receptor and the mechanism of dioxin toxicity. Biochem. J. 276:1991;273-287
34. Lewis S.J., Cherry N.M., McL Niven R., Barber P.V., Wilde K., Povey A.C. Cotinine levels and self-reported smoking status in patients attending a bronchoscopy clinic. Biomarkers. 8:2003;218-239
35. Lorenz J., Schmassmann H., Ohnhaus E., Oesch F. Activities of polycyclic hydrocarbon activating and inactivating enzymes in human lungs of smokers, non-smokers, lung-cancer and non-cancer patients. Arch. Toxicol., Suppl. 2:1979;483-489
36. Luch A., Coffing S.L., Tang Y.M., Schneider A., Soballa V., Greim H., Jefcoate C.R., Seidel A., Greenlee W.F., Baird W.M., Doehmer J. Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene. Chem. Res. Toxicol. 11:1998;686-695
37. McLemore T.L., Adelberg S., Liu M.C., McMahon N.A., Yu S.J., Hubbard W.C., Czerwinski M., Wood T.G., Storeng R., Lubet R.A., et al. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J. Natl. Cancer Inst. 82:1990;1333-1339
38. McManus M.E., Boobis A.R., Pacifici G.M., Frempong R.Y., Brodie M.J., Kahn G.C., Whyte C., Davies D.S. Xenobiotic metabolism in the human lung. Life Sci. 26:1980;481-487
39. Murray G.I., Taylor M.C., McFadyen M.C., McKay J.A., Greenlee W.F., Burke M.D., Melvin W.T. Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res. 57:1997;3026-3031
40. Muskhelishvili L., Thompson P.A., Kusewitt D.F., Wang C., Kadlubar F.F. In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in normal human tissues. J. Histochem. Cytochem. 49:2001;229-236
41. Nebert D.W. Role of genetics and drug metabolism in human cancer risk. Mutat. Res. 247:1991;267-281
42. Nebert D.W., Gelboin H.V. Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture: I. Assay and properties of induced enzyme. J. Biol. Chem. 243:1968;6242-6249
43. Nebert D.W., Petersen D.D., Puga A. Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin. Pharmacogenetics. 1:1991;68-78
44. Nebert D.W., Ingelman-Sundberg M., Daly A.K. Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues. Drug Metab. Rev. 31:1999;467-487
45. Niewoehner D.E., Kleinerman J., Rice D.B. Pathologic changes in the peripheral airways of young cigarette smokers. N. Engl. J. Med. 291:1974;755-758
46. Okey A.B. Enzyme induction in the cytochrome P-450 system. Pharmacol. Ther. 45:1990;241-298
47. Otto S., Bhattacharyya K.K., Jefcoate C.R. Polycyclic aromatic hydrocarbon metabolism in rat adrenal, ovary, and testis microsomes is catalyzed by the same novel cytochrome P450 (P450RAP). Endocrinology. 131:1992;3067-3076
48. Pass, H.I., 1996. Lung Cancer: Principles and Practice. Lippincott-Raven, Philadelphia, p. xviii, 982, [8] of plates.
49. Pipari R., Savela K., Nurminen T., Hukkanen J., Raunio H., Hakkola J., Mäntylä M., Beaune P., Edwards R.J., Boobis A.R., Antila S. Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers. Int. J. Cancer. 86:2000;610-616
50. Poland A., Knutson J.C. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22:1982;517-554
51. Prough R.A., Sipal Z., Jakobsson S.W. Metabolism of benzo(a)pyrene by human lung microsomal fractions. Life Sci. 21:1977;1629-1635
52. Prough R.A., Patrizi V.W., Okita R.T., Masters B.S., Jakobsson S.W. Characteristics of benzo(a)pyrene metabolism by kidney, liver and lung microsomal fractions from rodents and humans. Cancer Res. 39:1979;199-206
53. Rendic S., Di Carlo F.J. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab. Rev. 29:1997;413-580
54. Rojas M., Camus A.M., Alexandrov K., Husgafvel-Pursiainen K., Anttila S., Vainio H., Bartsch H. Stereoselective metabolism of (-)-benzo[a]pyrene-7,8-diol by human lung microsomes and peripheral blood lymphocytes: effect of smoking. Carcinogenesis. 13:1992;929-933
55. Saarikoski S.T., Husgafvel-Pursiainen K., Hirvonen A., Vainio H., Gonzalez F.J., Anttila S. Localization of CYP1A1 mRNA in human lung by in situ hybridization: comparison with immunohistochemical findings. Int. J. Cancer. 77:1998;33-39
56. Samet, J.M., 1994. Epidemiology of Lung Cancer. M. Dekker, NY, p. xvi, 543.
57. Shields P.G., Harris C.C. Molecular epidemiology and the genetics of environmental cancer. JAMA. 266:1991;681-687
58. Shimada T., Yun C.H., Yamazaki H., Gautier J.C., Beaune P.H., Guengerich F.P. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol. Pharmacol. 41:1992;856-864
59. Shimada T., Yamazaki H., Mimura M., Inui Y., Guengerich F.P. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270:1994;414-423
60. Shimada T., Hayes C.L., Yamazaki H., Amin S., Hecht S.S., Guengerich F.P., Sutter T.R. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56:1996;2979-2984
61. Shimada T., Yamazaki H., Mimura M., Wakamiya N., Ueng Y.F., Guengerich F.P., Inui Y. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. Drug Metab. Dispos. 24:1996;515-522
62. Shou M., Korzekwa K.R., Crespi C.L., Gonzalez F.J., Gelboin H.V. The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol. Mol. Carcinog. 10:1994;159-168
63. Sipal Z., Ahlenius T., Bergstrand A., Rodriquez L., Jakobsson S.W. Oxidative biotransformation of benzo(a)pyrene by human lung microsomal fractions prepared from surgical specimens. Xenobiotica. 9:1979;633-645
64. Spink D.C., Spink B.C., Cao J.Q., Gierthy J.F., Hayes C.L., Li Y., Sutter T.R. Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells. J. Steroid Biochem. Mol. Biol. 62:1997;223-232
65. Spivak S.D., Hurteau G.J., Reilly A.A., Aldous K.M., Ding X., Kaminsky L.S. CYP1B1 expression in human lung. Drug Metab. Dispos. 29:2001;916-922
66. Stoner G.D., Harris C.C., Autrup H., Trump B.F., Kingsbury E.W., Myers G.A. Explant culture of human peripheral lung: I. Metabolism of benzo[alpha]pyrene. Lab. Invest. 38:1978;685-692
67. Sutter T.R., Guzman K., Dold K.M., Greenlee W.F. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1 beta. Science. 254:1991;415-418
68. Sutter T.R., Tang Y.M., Hayes C.L., Wo Y.Y., Jabs E.W., Li X., Yin H., Cody C.W., Greenlee W.F. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem. 269:1994;13092-13099
69. Swanson H.I., Bradfield C.A. The AH-receptor: genetics, structure and function. Pharmacogenetics. 3:1993;213-330
70. Tang Y.M., Wo Y.Y.P., Stewart J., Hawkins A.L., Griffin C.A., Sutter T.R., Greenlee W.F. Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J. Biol. Chem. 271:1996;28324-28330
71. Walker N.J., Crofts F.G., Li Y., Lax S.F., Hayes C.L., Strickland P.T., Lucier G.W., Sutter T.R. Induction and localization of cytochrome P450 1B1 (CYP1B1) protein in livers of TCDD-treated rats: detection using polyclonal antibodies raised to histidine-tagged fusion proteins produced and purified from bacteria. Carcinogenesis. 19:1998;395-402
72. Walker N.J., Portier C.J., Lax S.F., Crofts F.G., Li Y., Lucier G.W., Sutter T.R. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 154:1999;279-286
73. Watanabe M., Abe T. Aryl hydrocarbon hydroxylase and its components in human lung microsomes. Gann. 72:1981;180-806
74. Wei C., Caccavale R.J., Kehoe J.J., Thomas P.E., Iba M.M. CYP1A2 is expressed along with CYP1A1 in the human lung. Cancer Lett. 171:2001;113-120
75. Wheeler C.W., Guenthner T.M. Cytochrome P-450-dependent metabolism of xenobiotics in human lung. J. Biochem. Toxicol. 6:1991;163-169
76. Wheeler C.W., Park S.S., Guenthner T.M. Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomes. Mol. Pharmacol. 38:1990;634-643
77. Whitlock J.P. Jr. The control of cytochrome P-450 gene expression by dioxin. Trends Pharmacol. Sci. 10:1989;285-288
78. Whitlock J.P. Jr. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39:1999;103-125
79. Whitlock J.P. Jr., Okino S.T., Dong L., Ko H.P., Clarke-Katzenberg R., Ma Q., Li H. Cytochromes P450 5: induction of cytochrome P4501A1: a model for analyzing mammalian gene transcription. FASEB J. 10:1996;809-818
80. Willey J.C., Coy E.L., Frampton M.W., Torres A., Apostolakos M.J., Hoehn G., Schuermann W.H., Thilly W.G., Olson D.E., Hammersley J.R., Crespi C.L., Utell M.J. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. Am. J. Respir. Cell Mol. Biol. 17:1997;114-124